Events & Presentations
Upcoming Events
- Upcoming Events
- Archive
-
Dec 14, 2021 at 2:00 PM EST2021 Virtual R&D Update and ASH Data Review
Genmab (Nasdaq: GMAB) will hold a brief virtual update to discuss progress in our innovative pipeline as well as key product data presented during the American Society of Hematology (ASH) Annual Meeting.
The event will be webcast live and will feature members of Genmab’s Executive Management Team and a variety of high-level Genmab speakers.
Dec 31, 2021Financial Calendar Year EndFeb 14, 2022Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsFeb 16, 2022Publication of the Annual Report for 2021 (after 5:00 PM CET)Mar 29, 2022Annual General Meeting 2022May 11, 2022Publication of the Interim Report for the First Quarter 2022 (after 5:00 PM CEST)Aug 10, 2022Publication of the Interim Report for the First Half 2022 (after 5:00 PM CEST)Nov 9, 2022Publication of the Interim Report for the First Nine Months 2022 (after 5:00 PM CET)Dec 31, 2022Financial Calendar Year End -
Nov 18, 2021 at 9:00 AM CETJefferies Virtual London Healthcare ConferenceFireside Chat with President and CEO, Jan van de Winkel.Nov 10, 2021Publication of the Interim Report for the First Nine Months 2021 (after 5:00 PM CET)
On November 10, Genmab announced financial results for the first nine months of 2021.
Sep 9, 2021 at 8:00 AM EDTMorgan Stanley 19th Annual Global Healthcare ConferenceFireside Chat with President and CEO, Jan van de Winkel.
Aug 11, 2021Publication of the Interim Report for the First Half 2021 (after 5:00 PM CEST)Genmab presented its first half 2021 financial results on August 11, 2021.Jun 8, 2021 from 3:50 PM to 4:30 PM EDTGoldman Sachs 42nd Annual Global Healthcare ConferenceFireside Chat with Chief Financial Officer, Anthony Pagano and Chief Development Officer, Judith Klimovsky
May 5, 2021Publication of the Interim Report for the First Quarter 2021 (after 5:00 PM CEST)On May 5, Genmab announced financial results for the first three months of 2021.Apr 13, 2021Annual General Meeting 2021Genmab A/S’ Annual General Meeting 2021 took place on Tuesday, April 13.Mar 23, 2021 from 3:30 PM to 4:15 PM CETInteractive Q&A Session with Genmab's CEOMar 1, 2021Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsFeb 23, 2021 from 11:00 AM to 12:00 AM ESTPublication of the Annual Report for 2020Dec 31, 2020Financial calendar year endDec 8, 2020 at 12:30 PM ESTGenmab 2020 ASH Data ReviewGenmab ASH Data Review 2020 3.2 MBNov 27, 2020 from 4:00 PM to 4:45 PM CETInteractive Q&A Session with Genmab's CEONov 17, 2020 at 9:40 AM ESTJefferies Virtual London Healthcare ConferenceFireside Chat with President and CEO, Jan van de Winkel and Executive Vice President and Chief Financial Officer, Anthony Pagano.
Nov 13, 2020 at 2:30 PM CETGenmab's Virtual Capital Markets DayGenmab hosted a virtual Capital Markets Day (CMD) for investors and analysts on Friday, 13 November, 2020. A replay of the event is available here.
Nov 4, 2020Publication of the Interim Report for the first nine months 2020 (after 5:00 PM CET)Sep 15, 2020 at 11:45 AM EDTMorgan Stanley 18th Annual Global Healthcare ConferenceFireside Chat with President and CEO, Jan van de Winkel and Executive Vice President and Chief Financial Officer, Anthony Pagano
Aug 26, 2020 at 4:30 PM CESTInteractive Q&A Session with Genmab's CEOAug 12, 2020Publication of the Interim Report for the first half 2020 (after 5:00 PM CEST)Jun 11, 2020 from 3:00 PM to 3:40 PM EDTGoldman Sachs 41st Annual Global Healthcare ConferenceFireside Chat with Executive Vice President and Chief Financial Officer, Anthony PaganoJun 10, 2020 from 1:00 PM to 2:00 PM CDTConference Call regarding Genmab and AbbVie PartnershipJun 2, 2020 from 8:30 AM to 8:55 AM EDTJefferies Virtual Healthcare Conference 2020Fireside chat with Genmab's President and CEO, Jan van de WinkelMay 11, 2020Interactive Q&A Session with Genmab's CEOMay 6, 2020Publication of the Interim Report for the first quarter 2020 (after 5:00 PM CET)May 6, 2020First Quarter 2020 Conference CallMar 26, 2020Annual General Meeting 2020Feb 26, 2020 at 2:30 PM CETInteractive Q&A Session with Genmab's CEOFeb 19, 2020 at 6:00 PM CET2019 Full Year Financial Results Conference CallFeb 19, 2020Publication of the Annual Report for 2019Feb 12, 2020Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 15, 2020 at 3:30 PM PST38th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US -
-